Showing 1 - 2 of 2
Persistent link: https://www.econbiz.de/10001144669
This paper models the launch decision of pharmaceutical companies in regard to new drugs and country markets. New drugs are launched with a delay or not launched at all in many countries. Considering that many of these new drugs would have created health benefits to the patients, there seems to...
Persistent link: https://www.econbiz.de/10012993196